| MPLT Stock | | | 17.42 0.21 1.19% |
Analyzing historical trends in various income statement and balance sheet accounts from MapLight Therapeutics' financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting MapLight Therapeutics' valuation are summarized below:
Market Capitalization | Earnings Share |
There are currently ninety-nine fundamental ratios for MapLight Therapeutics that can be evaluated and compared over time across peers in the industry. All traders should check MapLight Therapeutics' last-minute
fundamentals against the performance from
2010 to 2026 and make sure the trends continue to evolve in the right direction.
Enterprise Value is likely to drop to about 789.3
M in 2026
Check out the analysis of
MapLight Therapeutics Correlation against competitors.
MapLight Therapeutics Balance Sheet | | |
|
MapLight Therapeutics Income Statement | | |
|
MapLight Therapeutics Cash Flow Statement | | |
|
Financial Ratios | | |
|
MapLight Therapeutics Valuation Data | | |
|
MapLight Therapeutics shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although MapLight Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in MapLight Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on MapLight Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our
fundamental analysis page.
When running MapLight Therapeutics' price analysis, check to
measure MapLight Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MapLight Therapeutics is operating at the current time. Most of MapLight Therapeutics' value examination focuses on studying past and present price action to
predict the probability of MapLight Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MapLight Therapeutics' price. Additionally, you may evaluate how the addition of MapLight Therapeutics to your portfolios can decrease your overall portfolio volatility.